SEARCH
Quotes News NAV
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
Rubicon Research Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544578 INE506V01022 76.3063838 RUBICON 0 12,701.43 80.14 9.62 1
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.720.960.680.310.16
Long Term Debt-Equity Ratio0.160.270.220.120.06
Current Ratio1.491.351.642.453.02
Fixed Assets1.571.641.201.421.39
Inventory4.893.623.507.017.02
Debtors2.852.641.722.062.25
Interest Cover Ratio7.512.120.422.8810.49
PBIDTM (%)26.9715.7911.1714.3636.86
PBITM (%)23.9910.252.016.4828.48
PBDTM (%)23.7710.956.3612.1134.15
CPM (%)18.589.414.8712.0524.36
APATM (%)15.603.86-4.294.1715.98
ROCE (%)26.058.611.314.6821.00
RONW (%)29.306.39-4.723.9713.81